オリゴヌクレオチド合成の世界市場レポート 2025年

オリゴヌクレオチド合成の市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR16.9％で222億9,000万米ドルに成長します。予測期間の成長は、新たな診断ツール、RNA干渉（RNAi）療法、再生医療、ナノテクノロジー応用、遺伝子編集の進歩に起因すると考えられます。予測期間の主な動向には、標的薬開発、革新的デリバリーシステム、自動合成、CRISPR-cas技術、次世代シーケンシング（NGS）などがあります。

オリゴヌクレオチド合成市場の予測成長は、慢性疾患の有病率の増加によって推進されると予想されます。慢性疾患は、1年以上持続し、継続的な医学的治療を必要とすることを特徴とし、世界の健康問題です。オリゴヌクレオチドは、様々なメカニズムを通じて遺伝子発現に作用することで、慢性疾患に対処する上で重要な役割を果たしています。オリゴヌクレオチドは、mRNA、プレmRNA、あるいはノンコーディングRNAを標的として、スプライシングイベントを調節したり、分解を誘導したり、あるいはタンパク質の翻訳を妨害したりすることができます。例えば、2022年1月に国際糖尿病連合が報告したように、糖尿病の世界的有病率は2045年に12.2％増加し、20～79歳の年齢層で5億3,660万人に達すると予測されています。さらに、2022年9月の世界保健機関（WHO）によると、心血管疾患、がん、慢性呼吸器疾患、糖尿病を含む慢性疾患は、世界の非感染性疾患関連死亡のかなりの割合（74％）を占め、年間4,100万人が死亡しています。このような慢性疾患や希少疾患の有病率の上昇は、オリゴヌクレオチド合成市場の成長を促進する重要な要因です。

個別化医療に対する需要の高まりは、市場の成長に寄与すると予想されます。個別化医療は精密医療とも呼ばれ、個人の遺伝子や分子プロファイルを活用して予防や治療戦略を調整します。オリゴヌクレオチド合成は、特定の細胞プロセスを標的とする合成的に改変されたRNAまたはDNA鎖からなる低分子医薬品を提供することで、精密医療の開発において重要な役割を果たしています。個別化医療連合（PMC）は2022年10月に、様々なタイプのがん、遺伝的希少疾患、様々な慢性疾患や感染症に対応する75,000を超える遺伝子検査製品と300を超える個別化医薬品が市場に出回ると報告しています。このように、個別化医療に対する需要の高まりは、オリゴヌクレオチド合成市場の成長の重要な促進要因として認識されています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のオリゴヌクレオチド合成PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のオリゴヌクレオチド合成市場：成長率分析
• 世界のオリゴヌクレオチド合成市場の実績：規模と成長, 2019-2024
• 世界のオリゴヌクレオチド合成市場の予測：規模と成長, 2024-2029, 2034F
• 世界のオリゴヌクレオチド合成総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のオリゴヌクレオチド合成市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• カスタムオリゴ
• プレデザインオリゴ
• 世界のオリゴヌクレオチド合成市場：製品タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• オリゴヌクレオチド
• 試薬
• 装置
• サービス
• 精製
• 修正
• 世界のオリゴヌクレオチド合成市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 治療用途
• 研究用途
• 診断用途
• 世界のオリゴヌクレオチド合成市場、タイプ別サブセグメンテーション：カスタムオリゴ、実績と予測, 2019-2024, 2024-2029F, 2034F
• ロングオリゴヌクレオチド
• ショートオリゴヌクレオチド
• 修飾オリゴヌクレオチド
• 世界のオリゴヌクレオチド合成市場、タイプ別サブセグメンテーション：プレデザインオリゴ、実績と予測, 2019-2024, 2024-2029F, 2034F
• 遺伝子特異的オリゴ
• プローブオリゴ
• PCRおよびRT-PCR用プライマー

第7章 地域別・国別分析

• 世界のオリゴヌクレオチド合成市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のオリゴヌクレオチド合成市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• オリゴヌクレオチド合成市場：競合情勢
• オリゴヌクレオチド合成市場：企業プロファイル
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • GE HealthCare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Agilent Technologies Inc.
• Nitto Denko Avecia Inc.
• Alnylam Pharmaceuticals Inc.
• Maravai Life Sciences
• LGC Limited
• Ionis Pharmaceuticals Inc.
• GenScript Inc.
• Ajinomoto Bio-Pharma Services
• Sarepta Therapeutics Inc.
• Integrated DNA Technologies Inc.
• Twist Bioscience Corporation
• Eurogentec SA
• Kaneka Eurogentec S.A.
• Biocomma Limited
• Bio-Synthesis Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• オリゴヌクレオチド合成市場2029：新たな機会を提供する国
• オリゴヌクレオチド合成市場2029：新たな機会を提供するセグメント
• オリゴヌクレオチド合成市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Oligonucleotide synthesis refers to the chemical process of linking nucleotides in a precise sequence, resulting in the formation of a desired product. This method is widely utilized in modern laboratory practices, providing a rapid and cost-effective means to obtain customized oligonucleotides with specific sequences.

There are two primary types of oligonucleotide synthesis, custom oligos and predesigned oligos. Custom oligos are produced through solid-phase chemical synthesis, where the nucleic acids A, T, C, and G are sequentially added to create a chain of nucleotides. The range of products involved in this process includes oligonucleotides, reagents, equipment, services, purification, and modification. These products find applications in various fields, such as therapeutic applications, research applications, and diagnostic applications. Oligonucleotide synthesis is a versatile tool that plays a crucial role in creating tailored genetic sequences for diverse purposes in the scientific and medical communities.

The oligonucleotide synthesis market research report is one of a series of new reports from The Business Research Company that provides oligonucleotide synthesis market statistics, including oligonucleotide synthesis industry global market size, regional shares, competitors with a oligonucleotide synthesis market share, detailed oligonucleotide synthesis market segments, market trends and opportunities, and any further data you may need to thrive in the oligonucleotide synthesis industry. This oligonucleotide synthesis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The oligonucleotide synthesis market size has grown rapidly in recent years. It will grow from $10.33 billion in 2024 to $11.94 billion in 2025 at a compound annual growth rate (CAGR) of 15.6%. The growth in the historic period can be attributed to growth in biomedical research advancements, therapeutic development, biotechnology innovations, genomic studies, and increasing DNA technologies

The oligonucleotide synthesis market size is expected to see rapid growth in the next few years. It will grow to $22.29 billion in 2029 at a compound annual growth rate (CAGR) of 16.9%. The growth in the forecast period can be attributed to emerging diagnostic tools, RNA interference (RNAi) therapies, regenerative medicine, nanotechnology applications, and advancements in gene editing. Major trends in the forecast period include targeted drug development, innovative delivery systems, automated synthesis, CRISPR-cas technology, and next-generation sequencing (NGS).

The projected growth in the oligonucleotide synthesis market is expected to be propelled by the increasing prevalence of chronic diseases. Chronic diseases, characterized by lasting one year or longer and requiring ongoing medical attention, are a global health concern. Oligonucleotides play a crucial role in addressing chronic diseases by acting on gene expression through various mechanisms. They can target mRNA, pre-mRNA, or non-coding RNA to modulate splicing events, induce degradation, or interfere with protein translation. For instance, the global prevalence of diabetes is projected to increase by 12.2% in 2045, reaching 536.6 million individuals in the 20-79 age group, as reported by the International Diabetes Federation in January 2022. Additionally, chronic diseases, including cardiovascular diseases, cancer, chronic respiratory diseases, and diabetes, contribute to a significant percentage (74%) of global non-communicable disease-related deaths, with 41 million deaths annually, according to the World Health Organization in September 2022. This rising prevalence of chronic and rare diseases is a key driver fueling the growth of the oligonucleotide synthesis market.

The increasing demand for personalized medicine is expected to contribute to the market's growth. Personalized medicine, also known as precision medicine, leverages an individual's genetic and molecular profile to tailor prevention and treatment strategies. Oligonucleotide synthesis plays a vital role in developing precision medicines by providing small-molecule drugs composed of synthetically modified RNA or DNA strands that target specific cellular processes. The Personalized Medicine Coalition (PMC) reported in October 2022 that there will be over 75,000 genetic testing products and 300 personalized medicines on the market, catering to individuals with various types of cancer, genetic rare diseases, and a range of chronic and infectious diseases. The increasing demand for personalized medicine is thus identified as a significant driver for the oligonucleotide synthesis market's growth.

Product innovation is a significant trend gaining traction in the oligonucleotide synthesis market. Key companies are focusing on developing innovative products to maintain their competitive edge in the market. For example, in July 2024, Ansa Biotechnologies, Inc., a US-based manufacturer of complex DNA, introduced Ansa Clonal DNA and Ansa DNA Fragments. Ansa Clonal DNA delivers clonal, sequence-perfect DNA up to 600 base pairs in length, removing the need for assembly and providing unmatched accuracy for complex synthetic biology projects. This product guarantees error-free, ready-to-use DNA sequences, making it a dependable option for researchers. Ansa DNA Fragments offers sequence-verified linear double-stranded DNA fragments, also up to 600 base pairs, designed for various research applications. Through its innovative enzymatic synthesis process, Ansa consistently produces complex DNA constructs, including repeats and secondary structures, with high precision.

Major companies in the oligonucleotide synthesis market are focusing on introducing novel synthesis techniques, such as de novo synthesis, to gain a competitive edge. In March 2023, Ansa Biotechnologies, a U.S.-based biotechnology company, achieved a significant milestone by successfully de novo synthesizing the longest oligonucleotide in the world, comprising 1005 bases. This sequence encodes a crucial part of an Adeno-Associated Virus (AAV) vector used in gene therapy development. Overcoming challenges related to strong secondary structures and high GC content, this achievement allows for the direct synthesis of gene-length sequences, impacting the fields of genetic engineering and biotechnology.

In June 2024, GSK plc, a UK-based pharmaceutical company, acquired Elsie Biotechnologies for $50 million. This acquisition enables GSK to fully incorporate Elsie's technologies for oligonucleotide discovery, synthesis, and delivery into its research and development framework. This integration is anticipated to bolster GSK's current capabilities in creating oligonucleotide-based medicines. Elsie Biotechnologies is a US-based firm specializing in oligonucleotide therapeutics.

Major companies operating in the oligonucleotide synthesis market include Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, GE HealthCare Technologies Inc., Eurofins Scientific SE, Agilent Technologies Inc., Nitto Denko Avecia Inc., Alnylam Pharmaceuticals Inc., Maravai Life Sciences, LGC Limited, Ionis Pharmaceuticals Inc., GenScript Inc., Ajinomoto Bio-Pharma Services, Sarepta Therapeutics Inc., Integrated DNA Technologies Inc., Twist Bioscience Corporation, Eurogentec SA, Kaneka Eurogentec S.A., Biocomma Limited, Bio-Synthesis Inc., TriLink BioTechnologies Incorporated, Generi Biotech s.r.o., ATDBio Ltd., BioAutomation Corporation, Biolegio B.V., Dharmacon Research Inc.

North America was the largest region in the oligonucleotide synthesis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oligonucleotide synthesis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the oligonucleotide synthesis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The oligonucleotide synthesis market consists of revenues earned by entities by providing non-coding RNA inhibition, splicing modulation, gene activation, and programmed gene editing services. The market value includes the value of related goods sold by the service provider or included within the service offering. The oligonucleotide synthesis market also includes sales of RNAi oligonucleotides, antisense oligonucleotides, condensation activators, sulphur-transfer reagents, and deprotection reagents. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Oligonucleotide Synthesis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on oligonucleotide synthesis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for oligonucleotide synthesis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The oligonucleotide synthesis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Custom Oligos; Predesigned Oligos
• 2) By Product Type: Oligonucleotides; Reagents; Equipment; Services; Purification; Modification
• 3) By Application: Therapeutic Applications; Research Applications; Diagnostic Applications
• Subsegments:
• 1) By Custom Oligos: Long Oligonucleotides; Short Oligonucleotides; Modified Oligonucleotides
• 2) By Predesigned Oligos: Gene-Specific Oligos; Probe Oligos; Primers For PCR And RT-PCR
• Companies Mentioned: Thermo Fisher Scientific Inc.; Danaher Corporation; Merck KGaA; GE HealthCare Technologies Inc.; Eurofins Scientific SE
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Oligonucleotide Synthesis Market Characteristics

3. Oligonucleotide Synthesis Market Trends And Strategies

4. Oligonucleotide Synthesis Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Oligonucleotide Synthesis Growth Analysis And Strategic Analysis Framework

• 5.1. Global Oligonucleotide Synthesis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Oligonucleotide Synthesis Market Growth Rate Analysis
• 5.4. Global Oligonucleotide Synthesis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Oligonucleotide Synthesis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Oligonucleotide Synthesis Total Addressable Market (TAM)

6. Oligonucleotide Synthesis Market Segmentation

• 6.1. Global Oligonucleotide Synthesis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Custom Oligos
• Predesigned Oligos
• 6.2. Global Oligonucleotide Synthesis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oligonucleotides
• Reagents
• Equipment
• Services
• Purification
• Modification
• 6.3. Global Oligonucleotide Synthesis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Therapeutic Applications
• Research Applications
• Diagnostic Applications
• 6.4. Global Oligonucleotide Synthesis Market, Sub-Segmentation Of Custom Oligos, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Long Oligonucleotides
• Short Oligonucleotides
• Modified Oligonucleotides
• 6.5. Global Oligonucleotide Synthesis Market, Sub-Segmentation Of Predesigned Oligos, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Gene-Specific Oligos
• Probe Oligos
• Primers For PCR And RT-PCR

7. Oligonucleotide Synthesis Market Regional And Country Analysis

• 7.1. Global Oligonucleotide Synthesis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Oligonucleotide Synthesis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Oligonucleotide Synthesis Market

• 8.1. Asia-Pacific Oligonucleotide Synthesis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Oligonucleotide Synthesis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Oligonucleotide Synthesis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Oligonucleotide Synthesis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Oligonucleotide Synthesis Market

• 9.1. China Oligonucleotide Synthesis Market Overview
• 9.2. China Oligonucleotide Synthesis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Oligonucleotide Synthesis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Oligonucleotide Synthesis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Oligonucleotide Synthesis Market

• 10.1. India Oligonucleotide Synthesis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Oligonucleotide Synthesis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Oligonucleotide Synthesis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Oligonucleotide Synthesis Market

• 11.1. Japan Oligonucleotide Synthesis Market Overview
• 11.2. Japan Oligonucleotide Synthesis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Oligonucleotide Synthesis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Oligonucleotide Synthesis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Oligonucleotide Synthesis Market

• 12.1. Australia Oligonucleotide Synthesis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Oligonucleotide Synthesis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Oligonucleotide Synthesis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Oligonucleotide Synthesis Market

• 13.1. Indonesia Oligonucleotide Synthesis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Oligonucleotide Synthesis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Oligonucleotide Synthesis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Oligonucleotide Synthesis Market

• 14.1. South Korea Oligonucleotide Synthesis Market Overview
• 14.2. South Korea Oligonucleotide Synthesis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Oligonucleotide Synthesis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Oligonucleotide Synthesis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Oligonucleotide Synthesis Market

• 15.1. Western Europe Oligonucleotide Synthesis Market Overview
• 15.2. Western Europe Oligonucleotide Synthesis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Oligonucleotide Synthesis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Oligonucleotide Synthesis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Oligonucleotide Synthesis Market

• 16.1. UK Oligonucleotide Synthesis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Oligonucleotide Synthesis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Oligonucleotide Synthesis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Oligonucleotide Synthesis Market

• 17.1. Germany Oligonucleotide Synthesis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Oligonucleotide Synthesis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Oligonucleotide Synthesis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Oligonucleotide Synthesis Market

• 18.1. France Oligonucleotide Synthesis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Oligonucleotide Synthesis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Oligonucleotide Synthesis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Oligonucleotide Synthesis Market

• 19.1. Italy Oligonucleotide Synthesis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Oligonucleotide Synthesis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Oligonucleotide Synthesis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Oligonucleotide Synthesis Market

• 20.1. Spain Oligonucleotide Synthesis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Oligonucleotide Synthesis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Oligonucleotide Synthesis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Oligonucleotide Synthesis Market

• 21.1. Eastern Europe Oligonucleotide Synthesis Market Overview
• 21.2. Eastern Europe Oligonucleotide Synthesis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Oligonucleotide Synthesis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Oligonucleotide Synthesis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Oligonucleotide Synthesis Market

• 22.1. Russia Oligonucleotide Synthesis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Oligonucleotide Synthesis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Oligonucleotide Synthesis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Oligonucleotide Synthesis Market

• 23.1. North America Oligonucleotide Synthesis Market Overview
• 23.2. North America Oligonucleotide Synthesis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Oligonucleotide Synthesis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Oligonucleotide Synthesis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Oligonucleotide Synthesis Market

• 24.1. USA Oligonucleotide Synthesis Market Overview
• 24.2. USA Oligonucleotide Synthesis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Oligonucleotide Synthesis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Oligonucleotide Synthesis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Oligonucleotide Synthesis Market

• 25.1. Canada Oligonucleotide Synthesis Market Overview
• 25.2. Canada Oligonucleotide Synthesis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Oligonucleotide Synthesis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Oligonucleotide Synthesis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Oligonucleotide Synthesis Market

• 26.1. South America Oligonucleotide Synthesis Market Overview
• 26.2. South America Oligonucleotide Synthesis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Oligonucleotide Synthesis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Oligonucleotide Synthesis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Oligonucleotide Synthesis Market

• 27.1. Brazil Oligonucleotide Synthesis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Oligonucleotide Synthesis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Oligonucleotide Synthesis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Oligonucleotide Synthesis Market

• 28.1. Middle East Oligonucleotide Synthesis Market Overview
• 28.2. Middle East Oligonucleotide Synthesis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Oligonucleotide Synthesis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Oligonucleotide Synthesis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Oligonucleotide Synthesis Market

• 29.1. Africa Oligonucleotide Synthesis Market Overview
• 29.2. Africa Oligonucleotide Synthesis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Oligonucleotide Synthesis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Oligonucleotide Synthesis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Oligonucleotide Synthesis Market Competitive Landscape And Company Profiles

• 30.1. Oligonucleotide Synthesis Market Competitive Landscape
• 30.2. Oligonucleotide Synthesis Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. GE HealthCare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis

31. Oligonucleotide Synthesis Market Other Major And Innovative Companies

• 31.1. Agilent Technologies Inc.
• 31.2. Nitto Denko Avecia Inc.
• 31.3. Alnylam Pharmaceuticals Inc.
• 31.4. Maravai Life Sciences
• 31.5. LGC Limited
• 31.6. Ionis Pharmaceuticals Inc.
• 31.7. GenScript Inc.
• 31.8. Ajinomoto Bio-Pharma Services
• 31.9. Sarepta Therapeutics Inc.
• 31.10. Integrated DNA Technologies Inc.
• 31.11. Twist Bioscience Corporation
• 31.12. Eurogentec SA
• 31.13. Kaneka Eurogentec S.A.
• 31.14. Biocomma Limited
• 31.15. Bio-Synthesis Inc.

32. Global Oligonucleotide Synthesis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Oligonucleotide Synthesis Market

34. Recent Developments In The Oligonucleotide Synthesis Market

35. Oligonucleotide Synthesis Market High Potential Countries, Segments and Strategies

• 35.1 Oligonucleotide Synthesis Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Oligonucleotide Synthesis Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Oligonucleotide Synthesis Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer